scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to scPharmaceuticals' Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Scpharmaceuticals Inc. (SCPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 6,059,528 | $27,631,448 | +9% | 0.5% |
| 2. | Rubric Capital Management David Rosen | 4,775,000 | $21,774,000 | +36% | 0.35% |
| 3. | AIGH Investment Partners Orin Hirschman | 4,124,367 | $18,807,113 | +18% | 5.3% |
| 4. | Suvretta Capital Management Aaron Cowen | 2,049,009 | $9,343,481 | 0.29% | |
| 5. | Kingdon Capital Mark Kingdon | 800,000 | $3,648,000 | 0.4% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 21,658 | Large Shareholder | 252,858 | 2024-08-13 | Filing | |
| $4.00 | 478,342 | Large Shareholder | 5,806,670 | 2024-08-13 | Filing | |
| $5.25 | 762,380 | Large Shareholder | 5,328,328 | 2022-11-25 | Filing | |
| $3.91 | 5,000 | Director | 5,000 | 2021-12-03 | Filing | |
| $3.96 | 10,000 | Officer, Director | 46,962 | 2021-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.09 | 87,036 | Large Shareholder | 410,268 | 2022-10-10 | Filing | |
| $4.09 | 19,017 | Large Shareholder | 92,983 | 2022-10-10 | Filing | |
| $4.09 | 456,413 | Large Shareholder | 2,231,601 | 2022-10-10 | Filing | |
| $5.02 | 5,808 | Large Shareholder | 497,304 | 2022-10-06 | Filing | |
| $5.02 | 1,269 | Large Shareholder | 112,000 | 2022-10-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,863,439 | $11,683,762 | 0% | |
| 2. | 1,404,607 | $8,806,886 | 0.35% | |
| 3. | 1,393,525 | $8,737,402 | 0.04% | |
| 4. | 1,369,888 | $8,589,197 | 0% | |
| 5. | 1,200,647 | $7,528,057 | 1.99% |
News See All
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the scPharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the scPharmaceuticals Third Quarter 2023 Earnings Conference Call.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the scPharmaceuticals Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript
PJ Kelleher: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals Third Quarter 2022 Earnings Call. As a reminder, this conference is being recorded.
Is SCPH A Good Stock To Buy Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...